ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621.

Maureen M O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.